USADA announced today that Gabriele Guarini, an Italian athlete in the sport of cycling, has accepted a two-year suspension for committing an anti-doping rule violation.
Guarini, 49, admitted taking a banned Oxygen-Enhancing Peptide Hormone after testing positive as the result of a sample collected at the Gran Fondo New York on May 20, 2012. Oxygen-Enhancing Peptide Hormones are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”), and the World Anti-Doping Agency Prohibited List.
In his communications with USADA, Guarini accepted responsibility for his actions and apologized to those involved with the Gran Fondo New York including its organizers and competitors.
Guarini’s two-year period of ineligibility, began on June 3, 2012. As a result of the violation, Guarini has been disqualified from all competitive results achieved on and subsequent to May 20, 2012, including forfeiture of any medals, points, and prizes.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.